Teaching tolerance from birth.

The first years of life quietly shape a lifetime of immune balance, and one landmark trial rewrote advice that parents had followed for decades.

The immune system is not born finished. In the first months and years of life it is still learning, deciding, in effect, what to treat as friend and what to treat as threat. That early education can last a lifetime.

A reversal built on evidence

For years, parents of at-risk children were told to delay foods such as peanut, on the intuitive assumption that avoidance was safer. The Learning Early About Peanut (LEAP) trial overturned that advice. Among high-risk infants (those with severe eczema, egg allergy, or both), introducing peanut between 4 and 11 months of age reduced the development of peanut allergy by roughly 80% by five years of age.¹

Avoidance was the intuitive advice. The evidence said the opposite.

Tolerance that lasts

A follow-up study, LEAP-On, asked whether that protection depended on continued exposure. Children who had eaten peanut and then avoided it entirely for a full year remained about 74% less likely to be allergic than those who had avoided it all along², evidence that immune tolerance, once taught, could hold on its own.

The dual-exposure idea

Why would timing and route matter so much? The leading explanation is the dual-allergen-exposure hypothesis: exposure through inflamed or broken skin tends to prime the immune system toward allergy, while early exposure through the gut tends to teach tolerance.³ The same protein, met in a different way at a different moment, can send the immune system down opposite paths.

What it changes

Guidelines now recommend introducing allergenic foods such as peanut and egg early, around 4 to 6 months, for infants at high risk, rather than holding them back.³ It is a powerful reminder that immune balance is, in part, built early, and that the window to shape it is real.